A clinical trial is currently enrolling adults between the ages of 18 and 65 who have been diagnosed with Generalized Anxiety Disorder (GAD).
To pre-qualify for this study, participants must:
Be 18 to 65 years old with Generalized Anxiety Disorder (GAD)
Be currently taking Paroxetine, Escitalopram, Duloxetine, Venlafaxine ER, Fluoxetine, Sertraline, Citalopram, Venlafaxine IR, Desvenlafaxine, Milnacipran, Vilazodone, Bupropion, Mirtazapine for at least 8 weeks
Not be currently experiencing a depressive episode
Have no lifetime history or schizophrenia, schizoaffective disorder, bipolar I or II disorder, posttraumatic stress disorder, or develpmental/cognitive disorders
Additional eligibility criteria may apply. To learn more and find out if you
qualify, please contact our study team at (714) 999 6688.
